COCO

AI MemoPost-earnings T+1

Vita Coco

As of 2026-10-23/Post-earnings T+1/Confidence medium

Open ticker Back to Memos

Data freshness

AI Memo

As of 2026-10-23 • Model: RankAlpha Sentiment Codex

Decision Panel

Action, confidence, horizon, and decision blockers at a glance.

Action

—

Confidence

medium

Horizon

—

Key catalyst

Q3 beat and higher 2026 guidance face a market credibility test • 2026-10-30

Base target: $67 / p=50% prob

Biggest risk

Despite the beat and guidance increase, shares fell 7.09% on October 22. The company expects approximately 33% Q4 gross margin, and some year-to-date margin improvement came from tariff refunds; Copra adds mix and integration risk. A broader, verified post-print estimate-revision picture is not yet available. Price history; SEC earnings exhibit.

Invalidation

Break below $48 or thesis failure.

What would change my mind?

Q3 beat reported consensus on both sales and EPS, organic sales grew 18%, and 2026 guidance rose. Piper Sandler raised its target to $88 from $83 on October 23, maintained Overweight, and called the selloff overdone. SEC earnings exhibit; Piper Sandler report.

Research note

Recommendation

—

Confidence

medium

As of

2026-10-23

Base target

$67

p=50%

Bull target

$79

p=25%

Bear target

$48

p=25%

Key bullets

Fast scan of bull, bear, and watch items

BullKey bullets

2027 pricing and Copra integration could restore margin quality
Q3 beat reported consensus on both sales and EPS, organic sales grew 18%, and 2026 guidance rose.
Piper Sandler raised its target to $88 from $83 on October 23, maintained Overweight, and called the selloff overdone.

BearKey bullets

Copra contributed to private-label growth but also diluted Q3 gross margin; acquisition integration and product mix remain execution risks [#PR-2026-10-22].
SEC earnings exhibit.
Management expects Q4 gross margin of approximately 33%, with higher freight, product and transportation costs and no offsetting price actions until early 2027 [#PR-2026-10-22].

WatchKey bullets

Q3 beat and higher 2026 guidance face a market credibility test

Summary

High-level snapshot

Recommendation

Model confidence

medium

Timeframe

Asset

Equity

Trigger

Post-earnings T+1

Base case: $67 (p=50%)

Target spread vs base: +18% / -28%

Scenario probabilities

Bull Target: $79 (p=25%)Base Target: $67 (p=50%)Bear Target: $48 (p=25%)

Commentary

Primary evidence substantially improves on the earlier monitoring baseline, consistent with the deterministic positive prior and high evidence-quality score. Yet COCO closed October 22 at $59, down 7.09% after the release; the source does not establish a single cause for that move. Piper Sandler's October 23 target increase is one favorable revision, not proof of a broad analyst reset. The $59 anchor is the last completed close used here; October 23 intraday trading is not treated as a settled reversal. Social, options, short-interest and employee measures were unavailable, so their numeric placeholders above carry no signal. Price history; Piper Sandler report.

As of 2026-10-23 • Updated bi-weekly / post-earningsSource: Internal modelMethodology

Analyst Summary

Thesis highlights from the latest analysis

Bull Case

Bear Case

Drivers

Scannable catalysts and supporting factors

2027 pricing and Copra integration could restore margin quality

Scenarios

Bull Target (Scenario probability)

$79 / p=25% prob

Base Target (Scenario probability)

$67 / p=50% prob

Bear Target (Scenario probability)

$48 / p=25% prob

Analysis 2026-10-23 · RankAlpha Sentiment Codex

Analysis reference price unavailable. Targets are shown without scenario returns.

Sentiment & Exposure

News Sentiment (30d)

0.20

Social Sentiment (7d)

0.00

Events

Other notable items detected

EVENT2026-10-30
Q3 beat and higher 2026 guidance face a market credibility test
The company reported Q3 sales of about $244 million and diluted EPS of $0.58, versus reported consensus of $230.1 million and $0.53. It raised 2026 sales guidance to $810–$820 million from $790–$805 million and adjusted EBITDA guidance to $170–$175 million from $154–$161 million. The October 22 close nevertheless fell 7.09% to $59, making post-print reassessment the immediate catalyst [#8-K-2026-10-22] [#PR-2026-10-22]. SEC earnings exhibit; consensus report; price history.
Prob 70.00% • Move 6.00% • Priced-in 60.00%
EVENT2026-12-31
Fourth-quarter margin compression tests the stronger sales outlook
Management expects roughly 33% Q4 gross margin, versus 38% in Q3, citing higher costs and no offsetting price actions until early 2027. Whether volume growth and SG&A leverage protect earnings despite that margin step-down is the next operating test [#PR-2026-10-22]. SEC earnings exhibit.
Prob 65.00% • Move -9.00% • Priced-in 45.00%

Short-term Catalysts

Next few weeks

No short-term catalysts

Long-term Catalysts

Months to a year

2027 pricing and Copra integration could restore margin quality
2027-03-31
Q3 organic sales grew 18%, while private-label growth included the newly acquired Copra business. Management expects price actions in early 2027; evidence that pricing offsets ocean freight, logistics and adverse mix without impairing branded volume would support a more durable growth thesis [#PR-2026-10-22]. SEC earnings exhibit.
Prob 55% • Move 14% • Priced-in 35%

Risks

Copra contributed to private-label growth but also diluted Q3 gross margin; acquisition integration and product mix remain execution risks [#PR-2026-10-22]. SEC earnings exhibit.
Management expects Q4 gross margin of approximately 33%, with higher freight, product and transportation costs and no offsetting price actions until early 2027 [#PR-2026-10-22]. SEC earnings exhibit.
Tariff refunds benefited year-to-date gross margin by 240 basis points; that benefit should not be treated as recurring underlying margin expansion [#PR-2026-10-22]. SEC earnings exhibit.

Peers

Symbol	Summary
FIZZ	National Beverage is the closest supplied public beverage-brand comparator, but its broader portfolio limits a direct coconut-water growth or margin read-through.
FRPT	Freshpet is a loose premium consumer-brand growth comparator, not a direct beverage operating peer; its category economics should not set COCO's multiple.

Sources

Internal and external references used in this analysis

Model source: RankAlpha Sentiment Codex
Analysis date: 2026-10-23

Loading AI feed…

Symbol

Summary

FIZZ

National Beverage is the closest supplied public beverage-brand comparator, but its broader portfolio limits a direct coconut-water growth or margin read-through.

FRPT

Freshpet is a loose premium consumer-brand growth comparator, not a direct beverage operating peer; its category economics should not set COCO's multiple.